These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3686467)

  • 1. [Does a specific withdrawal syndrome from non-dopaminergic antiparkinson agents exist?].
    George V; Castot A; Bidault I
    Therapie; 1987; 42(4):339-41. PubMed ID: 3686467
    [No Abstract]   [Full Text] [Related]  

  • 2. [Withdrawal of non-dopaminergic antiparkinson drugs].
    Le Bellec M; George V
    J Toxicol Clin Exp; 1985; 5(1):47-53. PubMed ID: 3843760
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse effects of antiparkinson drug withdrawal.
    Jellinek T; Gardos G; Cole JO
    Am J Psychiatry; 1981 Dec; 138(12):1567-71. PubMed ID: 6118066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism hyperpyrexia syndrome caused by abrupt withdrawal of ropinirole.
    Arora A; Fletcher P
    Br J Hosp Med (Lond); 2013 Dec; 74(12):698-9. PubMed ID: 24326721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complications of drug withdrawal from antiparkinson agents and neuroleptics].
    Mizon JP; Rosa A
    Therapie; 1984; 39(4):421-5. PubMed ID: 6148792
    [No Abstract]   [Full Text] [Related]  

  • 7. [Levodopa withdrawal symptoms in a non-Parkinsonian patient].
    Cabo-López I; García-Bermejo P; García-Ruiz PJ
    Rev Neurol; 2007 Aug 1-15; 45(3):190. PubMed ID: 17661281
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium.
    Lawrence JM
    Psychosomatics; 1985 Nov; 26(11):869-74, 877. PubMed ID: 2867577
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tactile hallucinations induced by trihexyphenidyl in a patient with Parkinson's disease].
    Funakawa I; Jinnai K
    Rinsho Shinkeigaku; 2005 Feb; 45(2):125-7. PubMed ID: 15782612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion.
    van Laar T; Lammers GJ; Roos RA; Gerritsen JJ; Meinders AE
    Mov Disord; 1998 Jan; 13(1):176-8. PubMed ID: 9452348
    [No Abstract]   [Full Text] [Related]  

  • 11. Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy.
    Suzuki K; Awata S; Nakagawa K; Takano T; Matsuoka H
    Mov Disord; 2006 Jan; 21(1):123-4. PubMed ID: 16250024
    [No Abstract]   [Full Text] [Related]  

  • 12. Trihexyphenidyl withdrawal encephalopathy.
    Johkura K; Matsumoto S; Hasegawa O; Kuroiwa Y
    Ann Neurol; 1997 Jan; 41(1):133-4. PubMed ID: 9005879
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H
    Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphous bullous erythema and trihexiphenidyl (or why police questioning is not always the most productive method)].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2007 Nov; 134(11):899. PubMed ID: 18033085
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Dependence on antiparkinsonian drugs.
    Marriott P
    Br Med J; 1976 Jan; 1(6002):152. PubMed ID: 1247752
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticholinergic exacerbation of phenothiazine-induced extrapyramidal syndrome.
    Alpert M; Diamond F; Laski EM
    Am J Psychiatry; 1976 Sep; 133(9):1073-5. PubMed ID: 961932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postoperative respiratory failure resulting from perioperative withdrawal of antiparkinsonian medications].
    Koganei H; Tanaka S; Iijima K; Horikawa Y; Tanaka O
    Masui; 1999 Jan; 48(1):70-2. PubMed ID: 10036894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrupt versus gradual withdrawal of antiparkinsonians.
    Weiner WJ
    Am J Psychiatry; 1982 Feb; 139(2):256-7. PubMed ID: 6119914
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats.
    Myhrer T; Enger S; Aas P
    Pharmacol Biochem Behav; 2008 Jun; 89(4):633-8. PubMed ID: 18384867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.